Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A3 | Q01959 | 7/20 | 0.42 |
| ▸ | SLC6A4 | P31645 | 6/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 3/20 | 0.34 |
| ▸ | ESR1 | P03372 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29635938 | 0.83 | ESR2 (0.43) | SLC6A3SLC6A4ESR1HCAR2 | |
| SCHEMBL27864843 | 0.83 | ESR2 (0.43) | SLC6A3SLC6A4ESR1HCAR2 | |
| SCHEMBL28032986 | 0.83 | SMN1; SMN2 (0.45) | SLC6A3SLC6A4TSHR | |
| SCHEMBL22552682 | 0.78 | TSHR (0.48) | SLC6A3SLC6A4TSHR | |
| SCHEMBL20819995 | 0.78 | TSHR (0.48) | SLC6A3SLC6A4TSHR | |
| SCHEMBL20819997 | 0.78 | TSHR (0.48) | SLC6A3SLC6A4TSHR | |
| SCHEMBL27593184 | 0.76 | MAPT (0.33) | SLC6A3TSHR | |
| SCHEMBL27565158 | 0.76 | SLC6A3 (0.31) | SLC6A3 | |
| SCHEMBL32688998 | 0.76 | SLC6A3 (0.43) | SLC6A3SLC6A4 | |
| SCHEMBL10394107 | 0.72 | SLC6A3 (0.43) | SLC6A3SLC6A4ESR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4709708-A1 | NOVEL CARBOXAMIDE DERIVATIVES | ANGELINI PHARMA S.P.A. (IT) | 2026-03-18 | — | — | EP | disclosed |
| WO-2024233603-A1 | NOVEL CARBOXAMIDE DERIVATIVES | ICAGEN, LLC (US) | 2024-11-14 | — | — | WO | disclosed |